Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • FSLR vs MRNA✓SelectedUSD · MRNAFSLR vs MRNA performance historyLatest closeAs of-5.84%11/17
Stock and ETF performance explorer

FSLR vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+47.2%
MRNA return
-11.9%
Excess return
+59.1%
Maximum drawdown
-60.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-5.8%-3.9%-1.9%-5.5%
7D-15.5%-17.6%+2.1%-14.3%
30D-11.4%-5.1%-6.3%-11.2%
3M-29.8%+220.8%-250.6%-39.6%
6M-34.5%+321.7%-356.1%-47.0%
YTD-41.4%+601.3%-642.7%-57.9%
1Y-39.7%+735.2%-774.9%-58.1%
3Y-1.3%+170.5%-171.9%-18.0%
5Y+47.2%-14.6%+61.8%+38.4%
All+47.2%-11.9%+59.1%+38.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling